Skip to main content
COGNITION THERAPEUTICS INC logo

COGNITION THERAPEUTICS INC — Investor Relations & Filings

Ticker · CGTX ISIN · US19243B1026 US Professional, scientific and technical activities
Open in API
Filings indexed 281 across all filing types
Latest filing 2021-08-25 Regulatory Filings
Country US United States of America
Listing US CGTX

About COGNITION THERAPEUTICS INC

https://cogrx.com/

Cognition Therapeutics, Inc. is a clinical-stage neuroscience company that discovers and develops oral, small-molecule therapeutics for neurodegenerative disorders. The company's primary focus is on conditions such as Alzheimer's disease and Dementia with Lewy Bodies (DLB). Its therapeutic approach is centered on developing medications designed to target and modulate key cellular damage response mechanisms. By aiming to rescue trafficking deficits and restore normal cellular housekeeping functions, the company seeks to protect neurons, improve synaptic health, and ultimately address the cognitive decline associated with these diseases.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. There is no indication of the document being a report itself or an announcement. Given the lack of identifiable information and the fallback rule for documents that do not fit any specific category, the appropriate classification is Regulatory Filings (RNS). The document length is 15,000 characters, which is substantial, but without readable content, it cannot be classified as a financial or other specific report type.
2021-08-25 English
S-1/A
Regulatory Filings Classification · 100% confidence The document is an Amendment No. 2 to Form S-1 Registration Statement filed with the SEC by Cognition Therapeutics, Inc. The Form S-1 is a registration statement used for initial public offerings (IPOs) or other securities offerings under the Securities Act of 1933. The text includes detailed information about the offering, company overview, risk factors, financial data, management discussion, and other disclosures typical of a registration statement. It is not an annual report, earnings release, or any other financial report type. It is also not a proxy statement, voting results, or management change announcement. The document is a regulatory filing related to securities registration and offering. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is substantial (15,000 characters), and it is not merely an announcement of a report but the actual filing itself.
2021-08-20 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a detailed letter addressed to the SEC regarding a Registration Statement on Form S-1 filed by Cognition Therapeutics, Inc. It discusses the accounting treatment for stock-based compensation, fair value determinations of common stock, and valuation methodologies. The letter references the Management's Discussion and Analysis (MD&A) section of the Registration Statement and provides extensive financial and valuation data related to stock options and equity awards. The document is not a full financial report like an Annual Report or Interim Report, nor is it a simple announcement or certification. It is a supplemental letter providing detailed financial and accounting information to the SEC as part of the registration process for an IPO. This type of document is best classified under Regulatory Filings (RNS) because it is a regulatory submission that does not fit the other specific categories such as Annual Report, Earnings Release, or Proxy Statement. It is not a report publication announcement since it contains substantive financial and valuation discussion rather than just announcing a report's availability.
2021-07-30 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a letter from legal counsel responding to SEC staff comments on a Registration Statement on Form S-1 filed by Cognition Therapeutics, Inc. It references the amended S-1 filing and addresses specific SEC comments regarding exhibits. The document is a correspondence related to a regulatory filing rather than the filing itself. It is short (3070 characters) and primarily serves as a response letter to the SEC, not containing financial statements or detailed report content. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory correspondence and comment response.
2021-07-29 English
S-1/A
Regulatory Filings Classification · 95% confidence The document is an Amendment No. 1 to a Form S-1 Registration Statement filed with the SEC by Cognition Therapeutics, Inc. The Form S-1 is a registration statement used for initial public offerings (IPOs) and related securities offerings. The text includes details about the registration fee, indemnification of directors and officers, recent sales of unregistered securities, and exhibits related to the registration statement. There is no indication that this is a financial report, earnings release, or other types of filings such as annual reports or management reports. Instead, it is a regulatory filing related to securities registration under the Securities Act of 1933. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is substantial (15,000 characters), and it contains detailed regulatory information rather than just an announcement or certification, supporting this classification with high confidence.
2021-07-29 English
Regulatory Filings 2021
Regulatory Filings Classification · 90% confidence The provided document text appears to be heavily encoded or corrupted, containing no readable or meaningful content related to financial reporting, regulatory announcements, or corporate filings. There are no identifiable keywords, regulatory references, fiscal period dates, or document titles that would allow classification into any specific filing category. Given the lack of discernible information and the fallback rule for documents that do not fit any category, the appropriate classification is Regulatory Filings (RNS). The document length is sufficient to exclude it being a mere announcement, but the content is unintelligible, so it cannot be classified as a substantive report.
2021-07-21 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.